Small-molecule anti-COVID-19 drugs and a focus on China's homegrown mindeudesivir (VV116)
Description
The coronavirus disease 2019 (COVID-19) pandemic has stimulated tremendous efforts to develop therapeutic agents that target severe acute respiratory syndrome coronavirus 2 to control viral infection. So far, a few small-molecule antiviral drugs
